⌘K

Login Start Free

Home/Filings/4/0001725160-25-000030

4//SEC Filing

Skvarka Jan 4

Accession 0001725160-25-000030

CIK 0001725160other

View on SEC.gov Company Profile

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:45 PM ET

Size

4.7 KB

Accession

0001725160-25-000030

Insider Transaction Report

Form 4

Period: 2025-01-31

Zentalis Pharmaceuticals, Inc.ZNTL

Director

Transactions

Purchase
Common Stock
2025-01-31$1.72/sh+60,000$103,446→ 149,551 total

Documents

1 file

4
wk-form4_1738705494.xmlPrimary
FORM 4

Issuer

Zentalis Pharmaceuticals, Inc.

CIK 0001725160

Entity typeother

Related Parties

1

filerCIK 0001838042

Filing Metadata

Form type: 4
Filed: Feb 3, 7:00 PM ET
Accepted: Feb 4, 4:45 PM ET
Size: 4.7 KB

View on SEC.gov